Cargando…
Investigation of the Efficacy of Pyrantel Pamoate, Mebendazole, Albendazole, and Ivermectin against Baylisascaris schroederi in Captive Giant Pandas
SIMPLE SUMMARY: Giant pandas are key protected animals in China. Baylisascaris schroederi, a parasitic nematode, is one of the main health risks threatening them. We used four anthelmintics—pyrantel pamoate (PYR), mebendazole (MBZ), albendazole (ABZ), and ivermectin (IVM)—on 22 enrolled giant pandas...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9817530/ https://www.ncbi.nlm.nih.gov/pubmed/36611749 http://dx.doi.org/10.3390/ani13010142 |
_version_ | 1784864772812963840 |
---|---|
author | Lu, Yaxian Deng, Linhua Peng, Zhiwei Zhou, Mengchao Wang, Chengdong Han, Lei Huang, Shan Wei, Ming Wei, Rongping Tian, Lihong Li, Desheng Hou, Zhijun |
author_facet | Lu, Yaxian Deng, Linhua Peng, Zhiwei Zhou, Mengchao Wang, Chengdong Han, Lei Huang, Shan Wei, Ming Wei, Rongping Tian, Lihong Li, Desheng Hou, Zhijun |
author_sort | Lu, Yaxian |
collection | PubMed |
description | SIMPLE SUMMARY: Giant pandas are key protected animals in China. Baylisascaris schroederi, a parasitic nematode, is one of the main health risks threatening them. We used four anthelmintics—pyrantel pamoate (PYR), mebendazole (MBZ), albendazole (ABZ), and ivermectin (IVM)—on 22 enrolled giant pandas. The fecal egg count reduction (FECR) proportions were calculated using both the Markov chain Monte Carlo (MCMC) Bayesian mathematical model and the arithmetic mean based on fecal egg count data. Anthelmintic resistance (AR) was assessed based on the criteria recommended by the World Association for the Advancement of Veterinary Parasitology (WAAVP). We found that the nematode was suspected to be resistant to PYR. The number of eggs per gram in the feces of giant panda enrolled in the present study was increased near the end of the experiment. ABSTRACT: Baylisascaris schroederi is one of the main health risks threatening both wild and captive giant pandas. The administration of anthelmintics is a common method to effectively control B. schroederi infection, but there is a notable risk of anthelmintic resistance (AR) after long-term, constant use of anthelmintics. Four anthelmintics—pyrantel pamoate (PYR), mebendazole (MBZ), albendazole (ABZ), and ivermectin (IVM)—were each administered separately at intervals of 2 months to 22 enrolled giant pandas. The fecal egg count reduction (FECR) proportions were calculated by both the Markov chain Monte Carlo (MCMC) Bayesian mathematical model and the arithmetic mean. AR was assessed based on the criteria recommended by the World Association for the Advancement of Veterinary Parasitology (WAAVP). The estimated prevalence of B. schroederi infection was 34.1%. After treatment with PYR, MBZ, ABZ, and IVM, it was determined that MBZ, ABZ, and IVM were efficacious against B. schroederi, while nematodes were suspected to be resistant to PYR according to the fecal egg count reduction (FECR) proportions. |
format | Online Article Text |
id | pubmed-9817530 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-98175302023-01-07 Investigation of the Efficacy of Pyrantel Pamoate, Mebendazole, Albendazole, and Ivermectin against Baylisascaris schroederi in Captive Giant Pandas Lu, Yaxian Deng, Linhua Peng, Zhiwei Zhou, Mengchao Wang, Chengdong Han, Lei Huang, Shan Wei, Ming Wei, Rongping Tian, Lihong Li, Desheng Hou, Zhijun Animals (Basel) Article SIMPLE SUMMARY: Giant pandas are key protected animals in China. Baylisascaris schroederi, a parasitic nematode, is one of the main health risks threatening them. We used four anthelmintics—pyrantel pamoate (PYR), mebendazole (MBZ), albendazole (ABZ), and ivermectin (IVM)—on 22 enrolled giant pandas. The fecal egg count reduction (FECR) proportions were calculated using both the Markov chain Monte Carlo (MCMC) Bayesian mathematical model and the arithmetic mean based on fecal egg count data. Anthelmintic resistance (AR) was assessed based on the criteria recommended by the World Association for the Advancement of Veterinary Parasitology (WAAVP). We found that the nematode was suspected to be resistant to PYR. The number of eggs per gram in the feces of giant panda enrolled in the present study was increased near the end of the experiment. ABSTRACT: Baylisascaris schroederi is one of the main health risks threatening both wild and captive giant pandas. The administration of anthelmintics is a common method to effectively control B. schroederi infection, but there is a notable risk of anthelmintic resistance (AR) after long-term, constant use of anthelmintics. Four anthelmintics—pyrantel pamoate (PYR), mebendazole (MBZ), albendazole (ABZ), and ivermectin (IVM)—were each administered separately at intervals of 2 months to 22 enrolled giant pandas. The fecal egg count reduction (FECR) proportions were calculated by both the Markov chain Monte Carlo (MCMC) Bayesian mathematical model and the arithmetic mean. AR was assessed based on the criteria recommended by the World Association for the Advancement of Veterinary Parasitology (WAAVP). The estimated prevalence of B. schroederi infection was 34.1%. After treatment with PYR, MBZ, ABZ, and IVM, it was determined that MBZ, ABZ, and IVM were efficacious against B. schroederi, while nematodes were suspected to be resistant to PYR according to the fecal egg count reduction (FECR) proportions. MDPI 2022-12-29 /pmc/articles/PMC9817530/ /pubmed/36611749 http://dx.doi.org/10.3390/ani13010142 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Lu, Yaxian Deng, Linhua Peng, Zhiwei Zhou, Mengchao Wang, Chengdong Han, Lei Huang, Shan Wei, Ming Wei, Rongping Tian, Lihong Li, Desheng Hou, Zhijun Investigation of the Efficacy of Pyrantel Pamoate, Mebendazole, Albendazole, and Ivermectin against Baylisascaris schroederi in Captive Giant Pandas |
title | Investigation of the Efficacy of Pyrantel Pamoate, Mebendazole, Albendazole, and Ivermectin against Baylisascaris schroederi in Captive Giant Pandas |
title_full | Investigation of the Efficacy of Pyrantel Pamoate, Mebendazole, Albendazole, and Ivermectin against Baylisascaris schroederi in Captive Giant Pandas |
title_fullStr | Investigation of the Efficacy of Pyrantel Pamoate, Mebendazole, Albendazole, and Ivermectin against Baylisascaris schroederi in Captive Giant Pandas |
title_full_unstemmed | Investigation of the Efficacy of Pyrantel Pamoate, Mebendazole, Albendazole, and Ivermectin against Baylisascaris schroederi in Captive Giant Pandas |
title_short | Investigation of the Efficacy of Pyrantel Pamoate, Mebendazole, Albendazole, and Ivermectin against Baylisascaris schroederi in Captive Giant Pandas |
title_sort | investigation of the efficacy of pyrantel pamoate, mebendazole, albendazole, and ivermectin against baylisascaris schroederi in captive giant pandas |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9817530/ https://www.ncbi.nlm.nih.gov/pubmed/36611749 http://dx.doi.org/10.3390/ani13010142 |
work_keys_str_mv | AT luyaxian investigationoftheefficacyofpyrantelpamoatemebendazolealbendazoleandivermectinagainstbaylisascarisschroederiincaptivegiantpandas AT denglinhua investigationoftheefficacyofpyrantelpamoatemebendazolealbendazoleandivermectinagainstbaylisascarisschroederiincaptivegiantpandas AT pengzhiwei investigationoftheefficacyofpyrantelpamoatemebendazolealbendazoleandivermectinagainstbaylisascarisschroederiincaptivegiantpandas AT zhoumengchao investigationoftheefficacyofpyrantelpamoatemebendazolealbendazoleandivermectinagainstbaylisascarisschroederiincaptivegiantpandas AT wangchengdong investigationoftheefficacyofpyrantelpamoatemebendazolealbendazoleandivermectinagainstbaylisascarisschroederiincaptivegiantpandas AT hanlei investigationoftheefficacyofpyrantelpamoatemebendazolealbendazoleandivermectinagainstbaylisascarisschroederiincaptivegiantpandas AT huangshan investigationoftheefficacyofpyrantelpamoatemebendazolealbendazoleandivermectinagainstbaylisascarisschroederiincaptivegiantpandas AT weiming investigationoftheefficacyofpyrantelpamoatemebendazolealbendazoleandivermectinagainstbaylisascarisschroederiincaptivegiantpandas AT weirongping investigationoftheefficacyofpyrantelpamoatemebendazolealbendazoleandivermectinagainstbaylisascarisschroederiincaptivegiantpandas AT tianlihong investigationoftheefficacyofpyrantelpamoatemebendazolealbendazoleandivermectinagainstbaylisascarisschroederiincaptivegiantpandas AT lidesheng investigationoftheefficacyofpyrantelpamoatemebendazolealbendazoleandivermectinagainstbaylisascarisschroederiincaptivegiantpandas AT houzhijun investigationoftheefficacyofpyrantelpamoatemebendazolealbendazoleandivermectinagainstbaylisascarisschroederiincaptivegiantpandas |